DVAX - Dynavax Technologies Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 0.59
52-Week Change 3-36.32%
S&P500 52-Week Change 318.80%
52 Week High 312.42
52 Week Low 32.60
50-Day Moving Average 35.51
200-Day Moving Average 34.35

Share Statistics

Avg Vol (3 month) 31.19M
Avg Vol (10 day) 31.51M
Shares Outstanding 583.87M
Float 64.76M
% Held by Insiders 11.19%
% Held by Institutions 185.10%
Shares Short (Nov 29, 2019) 414.45M
Short Ratio (Nov 29, 2019) 413.75
Short % of Float (Nov 29, 2019) 423.10%
Short % of Shares Outstanding (Nov 29, 2019) 417.23%
Shares Short (prior month Oct 31, 2019) 416.44M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Nov 10, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-439.85%

Management Effectiveness

Return on Assets (ttm)-30.66%
Return on Equity (ttm)-228.85%

Income Statement

Revenue (ttm)29.97M
Revenue Per Share (ttm)0.45
Quarterly Revenue Growth (yoy)623.80%
Gross Profit (ttm)-77.69M
EBITDA -113.64M
Net Income Avi to Common (ttm)-159.08M
Diluted EPS (ttm)-2.38
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)174.95M
Total Cash Per Share (mrq)2.09
Total Debt (mrq)217.64M
Total Debt/Equity (mrq)555.82
Current Ratio (mrq)4.94
Book Value Per Share (mrq)0.47

Cash Flow Statement

Operating Cash Flow (ttm)-131.87M
Levered Free Cash Flow (ttm)-96.7M